SGN 30
Alternative Names: AC 10 mAb; Anti-CD30 antibody; SGN-30Latest Information Update: 18 Dec 2023
At a glance
- Originator Seattle Genetics
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action CD30 antigen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Hodgkin's disease; Primary cutaneous anaplastic large cell lymphoma